Eli Lilly just released impressive study results for retatrutide, an investigational weight loss drug that targets three ...

An expert explains how the new program, which launches July 1, will work and who is eligible ...

Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded ...

Lilly said people on the next-generation weight loss medication across three different dosages achieved weight loss of 19% to ...

The world of weight loss drugs can be confusing. There are so many types and brand names, and then there’s the big question: Does weight loss medication work? The short answer is yes. Weight loss ...

Eli Lilly's new experimental weight loss drug retatrutide yielded up to 28% weight loss, which is greater than that of ...

Eli Lilly this month unveiled startling new data that showed an experimental weight-loss drug caused people with obesity to ...

Retatrutide, an experimental injectable drug, targets three hormones related to weight loss.

It is thought about 1.6 million people are on weight-loss drugs in the UK. Some patients are able to get the injections ...

Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need to know before July 2026.

Eli Lilly is just wrapping up trials of its retatrutide, but consumers already are flocking to black-market versions. Can Lilly compete with copies of its own drug?